Transgenic mice susceptible to poliovirus
- PMID: 1846972
- PMCID: PMC50932
- DOI: 10.1073/pnas.88.3.951
Transgenic mice susceptible to poliovirus
Abstract
Poliovirus-sensitive transgenic mice were produced by introducing the human gene encoding cellular receptors for poliovirus into the mouse genome. Expression of the receptor mRNAs in tissues of the transgenic mice was analyzed by using RNA blot hybridization and the polymerase chain reaction. The human gene is expressed in many tissues of the transgenic mice just as in tissues of humans. The transgenic mice are susceptible to all three poliovirus serotypes, and the mice inoculated with poliovirus show clinical symptoms similar to those observed in humans and monkeys. Rabbit antipoliovirus serum detects the antigens mainly in motor neurons in the anterior horn of the spinal cord and in nerve cells in the medulla oblongata and pons of the paralyzed transgenic mice. Therefore, cell types sensitive to poliovirus in the central nervous system of the transgenic mice appear to be identical to those of humans and monkeys. Furthermore, many more doses of oral poliovirus vaccine strains than of the virulent strains are required to cause paralysis in the transgenic mice. This may reflect the observation that the virulent strain multiplies more efficiently in the central nervous system than the attenuated strain. Thus, the transgenic mice may become an excellent new animal model to study molecular mechanisms of pathogenesis of poliovirus and to assess oral poliovirus vaccines.
Similar articles
-
Poliovirus-sensitive transgenic mice as a new animal model.Dev Biol Stand. 1993;78:101-7. Dev Biol Stand. 1993. PMID: 8388819
-
Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.Virology. 1995 Feb 1;206(2):1075-83. doi: 10.1006/viro.1995.1030. Virology. 1995. PMID: 7856082
-
Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.Cell. 1990 Oct 19;63(2):353-62. doi: 10.1016/0092-8674(90)90168-e. Cell. 1990. PMID: 2170026
-
Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.Dev Biol Stand. 1993;78:109-16. Dev Biol Stand. 1993. PMID: 8388820 Review.
-
Development of a neurovirulent testing system for oral poliovirus vaccine with transgenic mice.Lab Anim Sci. 1997 Apr;47(2):118-20. Lab Anim Sci. 1997. PMID: 9150487 Review.
Cited by
-
A nonpolio enterovirus with respiratory tropism causes poliomyelitis in intercellular adhesion molecule 1 transgenic mice.Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13636-41. doi: 10.1073/pnas.0403998101. Epub 2004 Sep 7. Proc Natl Acad Sci U S A. 2004. PMID: 15353596 Free PMC article.
-
Poliovirus receptor CD155-targeted oncolysis of glioma.Neuro Oncol. 2004 Jul;6(3):208-17. doi: 10.1215/S1152851703000577. Neuro Oncol. 2004. PMID: 15279713 Free PMC article.
-
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria.J Virol. 2013 May;87(9):4907-22. doi: 10.1128/JVI.02954-12. Epub 2013 Feb 13. J Virol. 2013. PMID: 23408630 Free PMC article.
-
A second gene for the African green monkey poliovirus receptor that has no putative N-glycosylation site in the functional N-terminal immunoglobulin-like domain.J Virol. 1992 Dec;66(12):7059-66. doi: 10.1128/JVI.66.12.7059-7066.1992. J Virol. 1992. PMID: 1331508 Free PMC article.
-
Mutation of a single conserved nucleotide between the cloverleaf and internal ribosome entry site attenuates poliovirus neurovirulence.J Virol. 2005 Nov;79(22):14235-43. doi: 10.1128/JVI.79.22.14235-14243.2005. J Virol. 2005. PMID: 16254358 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases